What Researchers Did
Researchers evaluated the effectiveness of hyperbaric oxygen therapy (HBOT) in improving visual acuity in patients with branch retinal artery occlusion (BRAO) using a case series design.
What They Found
Patients received hyperbaric oxygen therapy (HBOT) at 5, 36, and 48 hours after the onset of ocular symptoms. Following HBOT, visual acuity improved both quantitatively and qualitatively in the analyzed cases.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could potentially serve as a rescue treatment for Canadian patients experiencing early-stage branch retinal artery occlusion. This therapy might be most beneficial when administered promptly, offering a chance for improved visual outcomes if reperfusion is still possible.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
As a case series, this study provides limited evidence and lacks a control group, making it difficult to generalize the findings.